You are here
Clinical Trials: Liver Disease
Discuss
Each Clinical Trial will open in a new browser window or tab.
Condition: Primary Biliary Cirrhosis
Intervention: Procedure: mesenchymal stem cell transplantation or placebo infusion via peripheral vein
Sponsor: Xijing Hospital of Digestive Diseases
Recruiting
Intervention: Procedure: mesenchymal stem cell transplantation or placebo infusion via peripheral vein
Sponsor: Xijing Hospital of Digestive Diseases
Recruiting
Condition: Acute-On-Chronic Liver Failure
Intervention: Procedure: mesenchymal stem cell transplantation or placebo infusion via peripheral vein
Sponsor: Xijing Hospital of Digestive Diseases
Recruiting
Intervention: Procedure: mesenchymal stem cell transplantation or placebo infusion via peripheral vein
Sponsor: Xijing Hospital of Digestive Diseases
Recruiting
Condition: Decompensated Liver Cirrhosis
Intervention: Biological: UC-MSC
Sponsors: Shandong Qilu Stem Cells Engineering Co., Ltd.; Shanghai Public Health Clinical Center; First Affiliated Hospital of Fujian Medical University; Yantai Hospital for Infectious Diseases; The Second Affiliated Hospital of Chongqing Medical University; Jinan Hospital for Infectious Diseases
Not yet recruiting
Intervention: Biological: UC-MSC
Sponsors: Shandong Qilu Stem Cells Engineering Co., Ltd.; Shanghai Public Health Clinical Center; First Affiliated Hospital of Fujian Medical University; Yantai Hospital for Infectious Diseases; The Second Affiliated Hospital of Chongqing Medical University; Jinan Hospital for Infectious Diseases
Not yet recruiting
Condition: Liver Cirrhosis
Intervention: Biological: MSC
Sponsor: Nanjing Medical University
Not yet recruiting
Intervention: Biological: MSC
Sponsor: Nanjing Medical University
Not yet recruiting
Condition: Decompensated Liver Cirrhosis
Intervention: Biological: Mesenchymal stem cell
Sponsor: Rohto Pharmaceutical Co., Ltd.
Recruiting - verified August 2017
Intervention: Biological: Mesenchymal stem cell
Sponsor: Rohto Pharmaceutical Co., Ltd.
Recruiting - verified August 2017
Condition: Liver Cirrhosis
Interventions: Procedure: mesenchymal stem cell transplantation via peripheral vein; Other: mesenchymal stem cell
Sponsor: Xijing Hospital of Digestive Diseases
Recruiting - verified July 2017
Interventions: Procedure: mesenchymal stem cell transplantation via peripheral vein; Other: mesenchymal stem cell
Sponsor: Xijing Hospital of Digestive Diseases
Recruiting - verified July 2017
Condition: End Stage Liver Disease
Interventions: Drug: Neupogen; Procedure: CD133 Cells Transplantation
Sponsors: National University Hospital, Singapore; Singapore General Hospital; Tan Tock Seng Hospital; Changi General Hospital Singapore
Recruiting - verified February 2017
Interventions: Drug: Neupogen; Procedure: CD133 Cells Transplantation
Sponsors: National University Hospital, Singapore; Singapore General Hospital; Tan Tock Seng Hospital; Changi General Hospital Singapore
Recruiting - verified February 2017
Condition: Alcoholic Hepatitis
Interventions: Drug: standard medical therapy; Drug: G-CSF; Drug: n-Acetylcysteine
Sponsor: Postgraduate Institute of Medical Education and Research
Recruiting - verified November 2016
Interventions: Drug: standard medical therapy; Drug: G-CSF; Drug: n-Acetylcysteine
Sponsor: Postgraduate Institute of Medical Education and Research
Recruiting - verified November 2016
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Fulvestrant
Sponsor: University of Pennsylvania
Recruiting - verified March 2017
Intervention: Drug: Fulvestrant
Sponsor: University of Pennsylvania
Recruiting - verified March 2017
Condition: Liver Failure
Intervention: Drug: umbilical cord blood mesenchymal stem cells
Sponsor: Sun Yat-sen University
Not yet recruiting - verified June 2016
Intervention: Drug: umbilical cord blood mesenchymal stem cells
Sponsor: Sun Yat-sen University
Not yet recruiting - verified June 2016
